Dr Reddys Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹8,753.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.85 per cent from ₹8,828.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.44 per cent.
Operating Profit
Operating Profit stands at ₹1,914.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 7.83 per cent from ₹2,077.20 crore. This corresponds to a year-on-year *(YoY) decline of 15.76 per cent.
PBDT
PBDT stands at ₹2,064.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.23 per cent from ₹2,249.40 crore. This corresponds to a year-on-year *(YoY) decline of 12.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,543.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.55 per cent from ₹1,744.80 crore. This corresponds to a year-on-year *(YoY) decline of 17.67 per cent.
Net Profit
Net Profit stands at ₹1,189.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.01 per cent from ₹1,336.80 crore. This represents a 15.28 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -1.05% | 0.41% | 4.97% | 2.99% | 7.91% | 8.19% |
| Torrent Pharma. | 0.66% | 3.02% | 5.37% | 7.38% | 14.74% | 35.28% |
| Cipla | -0.98% | 0.96% | 9.60% | 0.42% | -10.97% | -10.87% |
| Lupin | -3.36% | 1.15% | 1.94% | 7.87% | 19.65% | 16.51% |
| Mankind Pharma | 2.18% | 7.37% | 16.76% | 17.14% | 8.54% | -2.83% |
| Zydus Lifesci. | -0.13% | 4.13% | 2.56% | 5.83% | -0.86% | 6.13% |
| Aurobindo Pharma | 0.50% | 8.19% | 10.26% | 32.62% | 29.09% | 23.42% |
Company Info
Company Information
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth